Ans T. van der Ploeg

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo et al. · New England Journal of Medicine · 2010 · 747 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +13

Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk

Johanna M. P. van den Hout, Joep H. J. Kamphoven, Léon P. F. Winkel et al. · PEDIATRICS · 2004 · 354 citations

Life Sciences, Biochemistry, Molecular Medicine +12

Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up

Léon P. F. Winkel, Johanna M. P. van den Hout, Joep H. J. Kamphoven et al. · Annals of Neurology · 2004 · 231 citations

Life Sciences, Biochemistry, Enzymology +12

Disease severity in children and adults with Pompe disease related to age and disease duration

M.L.C. Hagemans, Léon P. F. Winkel, Wim C.J. Hop et al. · Neurology · 2005 · 185 citations

Public Health, Child Health, Pediatrics +11

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 184 citations · Full text

Veterinary Medicine, Internal Medicine, Pharmacotherapy +3